We are live on ! Find out more
RGLS icon

Regulus Therapeutics
RGLS

Delisted

RGLS was delisted on the 24th of June, 2025.

Back to rankings

39 hedge funds and large institutions have $84M invested in Regulus Therapeutics in 2013 Q2 according to their latest regulatory filings, with 39 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

20.71% more ownership

Funds ownership: 0% → 20.71% (+21%)

Holders
39
Holders Change
+39
Holders Change %
–
% of All Funds
1.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

RGLS Hedge Fund Activity: Q2 2013 in Review

39 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Regulus Therapeutics (RGLS) for Q2 2013, worth a combined $84M.

Buyers outnumbered sellers: 39 funds opened new RGLS positions and 0 closed out — a net gain of 39 holders — while 0 added to existing stakes and 0 trimmed.

  • 39 institutional investors held Regulus Therapeutics (RGLS) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $84M of Regulus Therapeutics stock for Q2 2013.
  • 39 funds opened new Regulus Therapeutics positions in Q2 2013 and 0 closed out, a net change of +39 holders.

Based on aggregated 13F filings for Q2 2013.